Prevention and Treatment of Cytomegalovirus Infections in Solid Organ Transplant Recipients

Infectious Disease Clinics of North America
Christine E Koval

Abstract

Despite advances in prevention and treatment, cytomegalovirus (CMV) infection and disease remain an expected problem in solid organ transplant recipients. Because of the effect of immunosuppressing medications, CMV primary, secondary, and reactivated infection requires antiviral medications to prevent serious direct and indirect effects of the virus. Side effects and drug resistance, however, often limit the capacity of traditional antiviral therapies. This article updates the clinician on current and promising approaches to the management and control of CMV in the solid organ transplant recipient.

Citations

Feb 9, 2020·Intensive Care Medicine·Elie AzoulayUNKNOWN Nine-i Investigators
Aug 30, 2019·Saudi Journal of Kidney Diseases and Transplantation : an Official Publication of the Saudi Center for Organ Transplantation, Saudi Arabia·Sora Yasri, Viroj Wiwanitkit
Mar 8, 2020·Enfermedades infecciosas y microbiología clínica·Jose Tiago SilvaJosé María Aguado
Apr 17, 2021·International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases·Jorge Andrade-SierraJuan José Nieves-Hernández
Dec 15, 2020·Transplantation·Benjamin P JonesJ Richard Smith

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antivirals

Antivirals are medications that are used specifically for treating viral infections. Discover the latest research on antivirals here.

Antivirals (ASM)

Antivirals are medications that are used specifically for treating viral infections. Discover the latest research on antivirals here.